Scientific Reports · 2019 · 35 citations · 18 references
Health ProfessionsGeriatric MedicineAgingClinical BiochemistryPulmonary Function TestingAge-related Physiologic ChangesAge-related Physiological ChangesAging PhysiologyInterstitial Lung DiseaseDesaturationInterstitial Lung AbnormalitiesKlotho DeficiencyKlotho FunctionLung Function DeclineLung Function TestingPulmonary Function DeclineRespiratory Aging
Interstitial lung abnormalities (ILA) represent aging-associated bilateral interstitial abnormalities in nondependent areas of the lung. However, the aging mechanisms associated with ILA remain uncertain. α-Klotho is an anti-aging molecule that decreases progressively with age, and abnormally low circulating levels of this protein have been revealed in several chronic-degenerative diseases. In this study, we evaluated α-Klotho serum concentrations in individuals with ILA, and examined whether its levels were associated with pulmonary function decline. α-Klotho was measured by ELISA in 50 respiratory asymptomatic adults with ILA and 150 healthy individuals over 60 years. Compared with controls, ILA subjects were predominantly older males, and showed lower lung diffusing capacity (DLCO), higher desaturation after exercise, and higher concentrations of serum matrix metalloprotease-7 (6.24 ± 4.1 versus 4.3 ± 1.7 ng/ml; p = 0.002). No differences were found in serum concentrations of α-Klotho. However, lower levels of this protein in ILA significantly correlated with lower values of forced vital capacity (Rho = 0.39; p = 0.005), forced expiratory volume in one second (Rho = 0.39; p = 0.005), and DLCO (Rho = 0.29, p = 0.04). These findings suggest that decreased concentrations of α-Klotho may be a predictive biomarker of accelerated decline of lung function in individuals with ILA.
18
Suppression of Aging in Mice by the Hormone Klotho
Hiroshi Kurosu, Masaya Yamamoto, Jeremy D. Clark et al. · Science · 2005 · 1.9K citations · Full text
Education, Endocrinology, Genetics +17
Association Between Interstitial Lung Abnormalities and All-Cause Mortality
Rachel K. Putman, Hiroto Hatabu, Tetsuro Araki et al. · JAMA · 2016 · 465 citations · Full text
<i>MUC5B</i> Promoter Polymorphism and Interstitial Lung Abnormalities
Gary M. Hunninghake, Hiroto Hatabu, Yuka Okajima et al. · New England Journal of Medicine · 2013 · 448 citations · Full text